Xilio Therapeutics, Inc. (BOATS:XLO) Financings
Financings
| Raise | Date |
|---|---|
| Public offering of pre-funded warrants Announced: about US$40M · US$0.5349 a share · Warrants at US$0.0001 · Leerink Partners Dealers: Leerink Partners (lead) Buyers: Coastlands Capital (led the financing; existing investor); Gilead Sciences, Inc.; OrbiMed; Perceptive Advisors Use of proceeds: Advance development of product candidates, working capital and general corporate purposes | Feb 12, 2026 |
| Public offering of pre-funded warrants accompanied by Series A, Series B and Series C warrants Closed: US$50M raised · US$0.7499 a share · Warrants at US$0.75 · Leerink Partners Dealers: Leerink Partners (lead) Buyers: Coastlands Capital; Frazier Life Sciences; Gilead Sciences, Inc.; Logos Capital; Samsara BioCapital Use of proceeds: Advance development of product candidates, working capital and general corporate purposes | Jun 5, 2025 |